EUVIMEDEUVIMED entdecken
Crossref

Two-year follow-up of musculoskeletal outcomes and quality of life in patients with mucopolysaccharidosis type IV and VI

Emine Genç, Canan Bilekyiğit Kurt, Naime Evrim Karadağ Saygi, Mehmet Mehdi Deveci, Emel Yilmaz Gümüş iD, Sebile Kılavuz iD, Özge Keniş Coşkun iD, Burcu Öztürk Hişmi iD

Journal of Pediatric Endocrinology and Metabolism · 24.06.2026

DOI: 10.1515/jpem-2025-0665 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Pediatric Endocrinology and Metabolism, online erschienen am 24.06.2026. Verfasst von Emine Genç und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physical Medicine and Rehabilitation, Marmara University, Faculty of Medicine, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Quality of Life, Enzyme Replacement Therapy, Mucopolysaccharidosis VI, Mucopolysaccharidosis IV. Die Arbeit nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Musculoskeletal abnormalities are common to mucopolysaccharidoses (MPS) and can negatively affect the patient’s quality of life. Data on course of musculoskeletal findings of MPS type IVA and VI are very insufficient. This study aimed to document the effect of regular enzyme replacement therapy (ERT) on musculoskeletal system and quality of life.

Methods

Patients diagnosed with MPS type IVA and VI aged≥5 years who were observed in the paediatric metabolic diseases’ outpatient clinic and physical medicine and rehabilitation clinic of our centre were evaluated. The musculoskeletal examination was performed with paediatric walking arms, legs and spine system (pGALS) and quality of life was evaluated using the Paediatric Outcome Data Collection Instrument (PODCI) scale.

Results

A total of 14 patients were followed in 24 months. Six of them were diagnosed with MPS type IVA while eight of them were diagnosed with MPS type VI. Mean current age was 11.57 ± 4.91 years, mean age at diagnosis was 2.83 ± 2.71 years and the mean age at ERT initiation was 4.33 ± 3.49 years for all patients. There were no significant differences between the initial and final PODCI scores. The pGALS examination showed that there has been a significant decrease in lower extremity pathology scores from 3.53 ± 2.10 to 1.76 ± 1.23 (p=0.03) and a decrease in total pGALS scores from 12.30 ± 5.02 to 9.92 ± 4.55 (p=0.00) while there were no significant changes in upper extremity and spine pathology scores.

Conclusions

Current treatment regimens provide partial stabilization of musculoskeletal pathologies in patients with MPS, but do not lead to an improvement in quality of life in this aspect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Quality of LifeEnzyme Replacement TherapyMucopolysaccharidosis VIMucopolysaccharidosis IVHumansChildFemaleMaleFollow-Up StudiesAdolescentChild, PreschoolPrognosis

Stichwörter der Autor:innen

mucopolysaccharidosesmusculoskeletalquality of life

Autor:innen und Institutionen

  • Department of Physical Medicine and Rehabilitation, Marmara University, Faculty of Medicine, Istanbul, Türkiye.
  • Department of Paediatrics, Division of Paediatric Metabolism and Nutrition, Marmara University, Faculty of Medicine, Istanbul, Türkiye.

ORCID-Profile: Emel Yilmaz Gümüş, Sebile Kılavuz, Özge Keniş Coşkun, Burcu Öztürk Hişmi

Zitieren

APA

Genç, E., Bilekyiğit Kurt, C., Evrim Karadağ Saygi, N., Mehdi Deveci, M., Yilmaz Gümüş, E., Kılavuz, S., Keniş Coşkun, Ö., & Hişmi, B. Ö. (2026). Two-year follow-up of musculoskeletal outcomes and quality of life in patients with mucopolysaccharidosis type IV and VI. Journal of Pediatric Endocrinology and Metabolism. https://doi.org/10.1515/jpem-2025-0665

Vancouver

Genç E, Bilekyiğit Kurt C, Evrim Karadağ Saygi N, Mehdi Deveci M, Yilmaz Gümüş E, Kılavuz S, et al. Two-year follow-up of musculoskeletal outcomes and quality of life in patients with mucopolysaccharidosis type IV and VI. Journal of Pediatric Endocrinology and Metabolism. 2026. doi:10.1515/jpem-2025-0665

BibTeX
@article{Gen2026,
  author = {Genç, Emine and Bilekyiğit Kurt, Canan and Evrim Karadağ Saygi, Naime and Mehdi Deveci, Mehmet and Yilmaz Gümüş, Emel and Kılavuz, Sebile and Keniş Coşkun, Özge and Hişmi, Burcu Öztürk},
  title = {Two-year follow-up of musculoskeletal outcomes and quality of life in patients with mucopolysaccharidosis type IV and VI},
  journal = {Journal of Pediatric Endocrinology and Metabolism},
  year = {2026},
  doi = {10.1515/jpem-2025-0665}
}
Kostenlos starten →